Vaxxas Selected as World Economic Forum Technology Pioneer 2015

Award Recognizes Significant Potential of Vaxxas’ Nanopatch Vaccines and Immunotherapies August 26th, 2014 Vaxxas, a biotechnology company commercializing a novel vaccine delivery platform, has been named a 2015 Technology Pioneer by the World Economic Forum. Vaxxas is one of 24 emerging technology companies from around the world and across all industries recognized for their potential to transform the future of business and …